Document:

Endo Pharmaceuticals Holdings Inc. Directors Deferred Compensation Plan

 Exhibit 10.13 
 ENDO PHARMACEUTICALS HOLDINGS INC. 
 DIRECTORS DEFERRED COMPENSATION PLAN

 (Effective January 1, 2008) 

 ENDO PHARMACEUTICALS HOLDINGS INC. 

DIRECTORS DEFERRED COMPENSATION PLAN 
  

							
	 ARTICLE I
	  	INTRODUCTION	  	 	1	  
	 1.1.    
	  	Purpose	  	 	1	  
	 1.2.    
	  	Effective Date	  	 	1	  
	 1.3.    
	  	Type of Plan	  	 	1	  
			
	 ARTICLE II
	  	DEFINITIONS	  	 	2	  
	 2.1.    
	  	“Account	  	 	2	  
	 2.2.    
	  	“Administrator:	  	 	2	  
	 2.3.    
	  	“Affiliate:	  	 	2	  
	 2.4.    
	  	“Beneficiary”	  	 	2	  
	 2.5.    
	  	“Board:	  	 	2	  
	 2.6.    
	  	“Change in Control”	  	 	2	  
	 2.7.    
	  	“Code”	  	 	3	  
	 2.8.    
	  	“Committee:	  	 	3	  
	 2.9.    
	  	“Company:	  	 	3	  
	 2.10.    
	  	“Company Stock”	  	 	3	  
	 2.11.    
	  	“Deferrable Compensation”	  	 	3	  
	 2.12.    
	  	“Director”	  	 	3	  
	 2.13.    
	  	“Election Form”	  	 	3	  
	 2.14.    
	  	“Employee”	  	 	3	  
	 2.15.    
	  	“ERISA”	  	 	4	  
	 2.16.    
	  	“Fair Market Value”	  	 	4	  
	 2.17.    
	  	“Fees”	  	 	4	  
	 2.18.    
	  	“Installment Payment”	  	 	4	  
	 2.19.    
	  	“Lump Sum Payment”	  	 	4	  
	 2.20.    
	  	“Participant”	  	 	4	  
	 2.21.    
	  	“Plan”	  	 	4	  
	 2.22.    
	  	“Plan Year”	  	 	4	  
	 2.23.    
	  	“Restricted Stock Unit”	  	 	4	  
	 2.24.    
	  	“Specified Employee”	  	 	4	  
	 2.25.    
	  	“Termination from Service”	  	 	5	  
	 2.26.    
	  	“Unforeseeable Emergency”	  	 	5	  
			
	 ARTICLE III
	  	PARTICIPATION BY DIRECTORS	  	 	6	  
	 3.1.    
	  	Participation	  	 	6	  
	 3.2.    
	  	Cessation of Participation	  	 	6	  
	 3.3.    
	  	Ineligible Status	  	 	6	  
			
	 ARTICLE IV
	  	PARTICIPANT DEFERRALS	  	 	7	  
	 4.1.    
	  	Deferral Elections – General	  	 	7	  
	 4.2.    
	  	First Year of Eligibility	  	 	7	  
	 4.3.    
	  	Deferral of Cash Fees and Stock Payment Fees	  	 	7	  

  
 i 

							
	 4.4.    
	  	Deferral of Restricted Stock Units	  	 	7	  
	 4.5.    
	  	Cessation of Deferral Elections	  	 	7	  
	 4.6.    
	  	Changes to Deferral Elections	  	 	8	  
			
	 ARTICLE V
	  	DISTRIBUTIONS	  	 	9	  
	 5.1.    
	  	Time of Payments	  	 	9	  
	 5.2.    
	  	Form of Payment	  	 	9	  
	 5.3.    
	  	Permissible Distribution	  	 	9	  
	 5.4.    
	  	Permissible Acceleration of Payment	  	 	10	  
	 5.5.    
	  	Permissible Delay of Payment	  	 	11	  
	 5.6.    
	  	Payment Deemed Timely	  	 	11	  
	 5.7.    
	  	Valuation of Distributions	  	 	11	  
			
	 ARTICLE VI
	  	ACCOUNTS	  	 	12	  
	 6.1.    
	  	Account	  	 	12	  
	 6.2.    
	  	Crediting of Earnings on Non-Stock Compensation	  	 	12	  
	 6.3.    
	  	Crediting of Earnings on Restricted Stock Units and Deferred Stock Payments	  	 	12	  
	 6.4.    
	  	Statement of Account	  	 	13	  
	 6.5.    
	  	Vesting	  	 	13	  
			
	 ARTICLE VII
	  	FUNDING AND PARTICIPANTS INTEREST	  	 	14	  
	 7.1.    
	  	Plan Unfunded	  	 	14	  
	 7.2.    
	  	Establishment of Grantor Trust	  	 	14	  
	 7.3.    
	  	Participants’ Interest in Plan	  	 	14	  
			
	 ARTICLE VIII
	  	ADMINISTRATION AND INTERPRETATION	  	 	15	  
	 8.1.    
	  	Administration	  	 	15	  
	 8.2.    
	  	Interpretation	  	 	15	  
	 8.3.    
	  	Records and Reports	  	 	15	  
	 8.4.    
	  	Payment of Expenses	  	 	15	  
	 8.5.    
	  	Indemnification for Liability	  	 	15	  
	 8.6.    
	  	Claims Procedure	  	 	15	  
	 8.7.    
	  	Review Procedure	  	 	16	  
	 8.8.    
	  	Legal Claims	  	 	16	  
	 8.9.    
	  	Participant and Beneficiary Information	  	 	16	  
			
	 ARTICLE IX
	  	AMENDMENT AND TERMINATION	  	 	17	  
	 9.1.    
	  	Amendment	  	 	17	  
	 9.2.    
	  	Termination of Plan	  	 	17	  
			
	 ARTICLE X
	  	MISCELLANEOUS PROVISIONS	  	 	19	  
	 10.1.    
	  	Right of Company to Take Actions	  	 	19	  
	 10.2.    
	  	Alienation or Assignment of Benefits	  	 	19	  
	 10.3.    
	  	Company’s Protection	  	 	19	  
	 10.4.    
	  	Construction	  	 	19	  

  
 ii 

							
	 10.5.    
	  	Headings	  	 	19	  
	 10.6.    
	  	Number and Gender	  	 	19	  
	 10.7.    
	  	Right to Withhold	  	 	19	  

  
 iii

 ENDO PHARMACEUTICALS HOLDINGS INC. 

DIRECTORS DEFERRED COMPENSATION PLAN 
 (Effective January 1, 2008) 
 ARTICLE I 

INTRODUCTION 
 1.1. Purpose. The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing non-employee Directors the opportunity to defer retainer fees,
stock payments, and restricted stock units. 
 1.2. Effective Date. The effective date of the Plan is January 1,
2008. 
 1.3. Type of Plan. The Plan is intended to be an unfunded plan of non-qualified deferred compensation that meets
the requirements of Code Section 409A. In the event that any provision of the Plan is inconsistent with Code Section 409A, the applicable provisions of Code Section 409A shall be deemed to automatically supersede such inconsistent
provision and the Plan shall be administered to comply with Code Section 409A. 

  
 1 

 ARTICLE II 
 DEFINITIONS 
 Where used in the Plan, the following initially
capitalized words and terms shall have the meanings specified below, unless the context clearly indicates to the contrary: 

2.1. “Account” means the recordkeeping account established by the Administrator for each Participant to which Deferrable
Compensation, and earnings thereon, are credited in accordance with Article VI of the Plan. An Account may consist of one or more sub-accounts established by the Administrator, as deemed necessary for efficient operation of the Plan. 

2.2. “Administrator” means the Committee or such individuals or entity designated by the Committee to administer the Plan.

 2.3. “Affiliate” means an entity, more than fifty percent (50%) of the total voting power of which is owned,
directly or indirectly, by the Company. 
 2.4. “Beneficiary” means such person(s) or legal entity that is designated
by a Participant under Section 8.9 to receive benefits hereunder after such Participant’s death. 
 2.5.
“Board” means the board of directors of the Company. 
 2.6. “Change in Control” means and shall be deemed
to occur upon a Change in Ownership, a Change in Effective Control, or a Change in Ownership of Substantial Assets. For this purpose: 
 (i) A “Change in Ownership” means that a person or group acquires more than fifty percent (50%) of the aggregate fair market value or voting power of the capital stock of the Company,
including for this purpose capital stock previously acquired by such person or group; provided, however, that a Change in Ownership shall not be deemed to occur hereunder if, at the time of any such acquisition, such person or group owns more than
fifty percent (50%) of the aggregate fair market value or voting power of the Company’s capital stock. 

(ii) A “Change in Effective Control” means that (a) a person or group acquires (or has acquired during the
immediately preceding twelve (12) month period ending on the date of the most recent acquisition by such person or group) ownership of the capital stock of the Company possessing thirty percent (30%) or more of the total voting power of
the Company, or (b) a majority of the members of the Board of the Company is replaced during any twelve (12) month period, whether by appointment or election, without endorsement by a majority of the members of the Board prior to the date
of such appointment or election. 

  
 2 

 (iii) A “Change in Ownership of Substantial Assets” means that any
person or group acquires (or has acquired during the immediately preceding twelve (12) month period ending on the date of the most recent acquisition) assets of the Company with an aggregate gross fair market value of not less than forty
percent (40%) of the aggregate gross fair market value of the assets of the Company immediately prior to such acquisition. For this purpose, gross fair market value shall mean the fair value of the affected assets determined without regard to
any liabilities associated with such assets. 
 The Board shall determine whether a Change in Control has
occurred hereunder in a manner consistent with the provisions of Code Section 409A and the regulations and applicable guidance promulgated thereunder. 
 2.7. “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any regulations and applicable guidance promulgated thereunder. References in the Plan to specific sections
of the Code shall be deemed to include any successor provisions thereto. 
 2.8. “Committee” means the committee
appointed by the Board, which shall consist of two or more persons, each of whom, unless otherwise determined by the Board, is an “outside director” within the meaning of Code Section 162(m) and a “non-employee director”
within the meaning of Rule 16b-3. 
 2.9. “Company” means Endo Pharmaceuticals Holdings Inc., a Delaware corporation.

 2.10. “Company Stock” means the common stock of the Company, par value $.01 per share. 

2.11. “Deferrable Compensation” means one hundred percent (100%) of Fees and Restricted Stock Units that would be payable
to a Director during a Plan Year but for the Director’s election to defer such Deferrable Compensation on his or her Election Form in accordance with Article IV of this Plan. 

2.12. “Director” means a director on the Board who is not an Employee. 

2.13. “Election Form” means such document(s) or form(s), which may be electronic, as prescribed and made available from time to
time by the Administrator, whereby a Director enrolls in the Plan as a Participant , elects to defer Deferrable Compensation pursuant to Article IV of this Plan, and/or makes investment elections pursuant to Section 6.2 of the Plan. 

2.14. “Employee” means a common law employee of the Company or an Affiliate. 

  
 3 

 2.15. “ERISA” means the Employee Retirement Income Security Act of 1974, as
amended. 
 2.16. “Fair Market Value” means (determined as of the applicable distribution or valuation date hereunder)
(i) the closing sales price per share of Company stock on the national securities exchange on which such stock is principally traded on the last preceding date on which there was a sale of such stock on such exchange, or (ii) if the shares
of Company stock are not listed or admitted to trading on any such exchange, the closing price as reported by the NASDAQ Stock Market for the last preceding date on which there was a sale of such stock on such exchange, or (iii) if the shares
of Company stock are not then listed on a national securities exchange or traded in an over-the-counter market or the value of such shares is not otherwise determinable, such value as determined by the Administrator in good faith upon the advice of
a qualified valuation expert. 
 2.17. “Fees” means the cash retainer fees payable by the Company to the Director.

 2.18. “Installment Payment” means a series of substantially equal annual payments of the Participant’s Account
paid over a period ranging from two (2) whole years to ten (10) whole years, as elected by the Participant, commencing as of the applicable payment date under the plan. For purposes of Section 4.6, an Installment Payment is treated as
a single payment. 
 2.19. “Lump Sum Payment” means a single sum distribution of the entire value of a
Participant’s Account. 
 2.20. “Participant” means any eligible Director who defers Deferrable Compensation to
this Plan by filing an Election Form and for whom an Account is maintained under the Plan. 
 2.21. “Plan” means the
Endo Pharmaceuticals Holdings Inc. Directors Deferred Compensation Plan. 
 2.22. “Plan Year” means the calendar year.

 2.23. “Restricted Stock Unit” means a unit representing a share of Company Stock that has been granted to a
Participant pursuant to the terms of a separate agreement or plan maintained by the Company or an Affiliate, and that is subject to a vesting schedule or other substantial risk of forfeiture. 

2.24 “Specified Employee” means a Participant who is determined to be a “specified employee” within the meaning of
Code Section 409A with respect to a Termination from Service occurring in any twelve (12) month period commencing on April 1 based on the Participant’s compensation with the Employer, as defined in Code Section 416(i)(1)(D),
and his or her status at the end of the immediately preceding Plan Year. For purposes of the determining whether a Participant is classified as a Specified 

  
 4 

 
Employee, compensation from a nonresident alien’s gross income under Section 1.415(c)-2(g)(5)(ii) on account of the location of the services or the identify of an Employer that is not
effectively connected with the conduct of a trade or business within the United States shall be excluded. 
 2.25.
“Termination from Service” means the date the Participant ceases to be a Director on account of a voluntary or involuntary separation from service, within the meaning of Code Section 409A, with the Board for any reason. 

2.26 “Unforeseeable Emergency” means with respect to a Participant, his or her spouse, dependents (as defined in Code
Section 152, without regard to Sections 152(b)(1), (b)(2), and (d)(1)(B)) or Beneficiary, a non-reimbursable severe financial hardship attributable to (i) a sudden and unexpected illness or accident or (ii) funeral expenses, and also
means with respect to the Participant (i) a property loss due to casualty that is not otherwise covered by insurance, (ii) imminent foreclosure or eviction from the Participant’s primary residence, or (iii) a similar
extraordinary and unforeseeable circumstance beyond the control of the Participant, as determined by the Administrator. For purposes of this Plan, the purchase of a home and the payment of college tuition are not Unforeseeable Emergencies.

  
 5 

 ARTICLE III 
 PARTICIPATION BY DIRECTORS 
 3.1. Participation.
Participation in this Plan is voluntary and is limited to eligible Directors who file Election Forms in accordance with Article IV. 
 3.2. Cessation of Participation. A Director shall remain eligible to file deferral elections under the Plan until the earlier of (i) the date the Administrator informs the Director that he or
she is no longer eligible to participate in the Plan, i.e., “Ineligible Status,” or (ii) the date such Director incurs a Termination from Service. 
 3.3. Ineligible Status. If the Administrator determines that a Director has “Ineligible Status,” effective as of the date of such determination, said ineligible Director shall no longer
be eligible to file deferral elections under the Plan. The Account of an ineligible Director shall be paid in accordance with Sections 5.1 and 5.2 of the Plan, except to the extent all or part of such Account is eligible for distribution of
accelerated payment as permitted in Sections 5.3 and 5.4. 

  
 6 

 ARTICLE IV 
 PARTICIPANT DEFERRALS 
 4.1. Deferral Elections –
General. A Participant’s deferral election for a Plan Year is irrevocable for such Plan Year; except to the extent a cessation of deferrals hereunder is required under Section 4.5. Amounts deferred under the Plan shall not be
distributed to a Participant except as expressly provided in Article V or as otherwise permitted under Code Section 409A. A deferral election hereunder shall be made on an Election Form and comply with the applicable requirements of this
Article IV. A Participant’s initial deferral election under the Plan shall designate the amount of Deferrable Compensation that is being deferred and the form of distribution (as permitted in Section 5.2(a)). Once effective under the Plan,
a Participant’s deferral election shall remain in effect under the Plan until it is terminated by operation of the Plan or changed by the Participant in accordance with Section 4.6 herein. The Administrator may establish procedures for
deferral elections as it deems necessary to comply with the requirements of this Article IV and Code Section 409A. 
 4.2.
First Year of Eligibility. Notwithstanding the timing requirements of Sections 4.3 and 4.4, a Director may elect to defer Deferrable Compensation by completing and executing an Election Form that specifies the amount or percentage of
compensation to be deferred within the thirty (30) day period immediately following the date he or she first becomes a Director, provided, that the compensation being deferred relates to services performed after the date of such election.

 4.3. Deferral of Cash Fees and Stock Payment Fees. A Director may elect to defer Fees payable for services performed
during a subsequent Plan Year by completing and executing an Election Form that specifies the amount or percentage of Fees to be deferred and filing it with the Administrator before expiration of the election period establish by the Administrator,
which period shall end no later than December 31 of the calendar year immediately preceding such Plan Year. The provision under this Section for the deferral of Fees shall apply both to Fees payable in cash and to Fees payable in shares of
Company Stock (“Stock Payments”) pursuant to the Endo Pharmaceuticals Inc. Directors Stock Election Plan (the “Directors Stock Election Plan”). 
 4.4. Deferral of Restricted Stock Units. A Director may elect to defer Restricted Stock Units by completing and executing an Election Form that specifies the amount or percentage of Restricted
Stock Units to be deferred and filing it with the Administrator on or before expiration of the election period established by the Administrator, which period shall end no later than December 31 of the calendar year immediately preceding the
Plan Year in which such Restricted Stock Units are granted. 
 4.5. Cessation of Deferral Elections. To the extent
provided for under Code Section 409A, a Participant’s deferral election(s) in effect under the Plan for a Plan Year in which a Participant is granted an Unforeseeable Emergency distribution in accordance with Section 5.3(b) hereof may
be terminated by the Administrator, effective as 

  
 7 

 
soon as practicable following the grant of such emergency distribution. If a Participant’s deferral elections under the Plan are terminated in accordance with the foregoing sentence, such
Participant shall be ineligible to make deferrals of compensation to the Plan for the six (6) month period following his or her receipt of the emergency distribution. Subject to the foregoing six (6) month limitation, the Participant may
make new deferral elections for Deferrable Compensation payable in subsequent Plan Years in accordance with this Article IV. 

4.6. Changes to Deferral Elections. A Participant shall be permitted a one-time election to change the form of payment relating to
the distribution of his or her Account to the extent permitted by the Administrator and in accordance with the requirements of Code Section 409A(a)(4)(C), including the requirements that such redeferral election (a) may not take effect
until at least twelve (12) months after such redeferral election is filed with the Administrator; (b) must result in the first distribution subject to the redeferral election being made at least five (5) years after the Termination
from Service; and (c) must be filed with the Administrator at least twelve (12) months before such Termination from Service. 

  
 8 

 ARTICLE V 
 DISTRIBUTIONS 
 5.1. Time of Payment. 

a. A Participant’s Account shall be distributed on the first day of the calendar month next following the
Participant’s Termination from Service. 
 b. Notwithstanding the foregoing, with respect to a Specified
Employee, a payment upon Termination from Service shall not be made earlier than the date that is at least six (6) months after the date of such Specified Employee’s Termination from Service. 

5.2. Form of Payment. 
 a. Except as otherwise provided under the Plan, a Participant’s Account shall be paid as a Lump Sum Payment or an Installment Payment, as elected by the Participant on his or her Election Form.

 b. In the absence of Participant’s election as to the form of payment, as permitted under subsection a,
above, a Participant’s Account shall be distributed in the form of a Lump Sum Payment. 
 c. Deferral of
Stock Payments and deferral of Restricted Stock Units shall be paid only in shares of Company Stock. 
 5.3. Permissible
Distributions. No distribution under the Plan shall be permitted except as set forth in this Section 5.3 or as otherwise permitted under the Plan and Code Section 409A(a)(2). 

a. Change in Control. Notwithstanding any provision of the Plan or Participant Election Form to the contrary, a
Participant who incurs a Termination from Service within the two (2) year period immediately following a Change in Control shall receive a Lump Sum Payment of his or her Account within thirty (30) days following the date of such
Termination from Service. 
 b. Unforeseeable Emergency. If a Participant experiences an Unforeseeable
Emergency, such Participant shall be permitted to withdraw all or a portion of his or her Account in the form of an immediate single-sum payment, subject to the limitations set forth below: 

(i) A request for withdrawal shall be made to the Administrator in writing and shall set forth the circumstances
surrounding the Unforeseeable Emergency. As a condition of and part of such request, the Participant shall provide to the Administrator his or her written representation that (A) the emergency cannot be relieved by 

  
 9 

 
insurance or other reimbursement reasonably available to the Participant, (B) the emergency can only be relieved by liquidation of the Participant’s assets and any such liquidation
would itself result in severe damage or injury to the Participant, (C) the Participant has no reasonable borrowing capacity to relieve the emergency, and (D) the emergency cannot be relieved by cessation of the Participant’s deferrals
under the Plan. The Administrator shall be entitled to request such additional information as may be reasonably required to determine whether an Unforeseeable Emergency exists or the amount of the emergency, and may establish additional conditions
precedent to the review or granting of a request for a withdrawal on account of an Unforeseeable Emergency. 

(ii) If the Administrator determines that an Unforeseeable Emergency exists, the Administrator shall authorize the
immediate distribution of the amount required to meet the financial need created by such Unforeseeable Emergency, including any taxes payable on such amount, and, if required, the cessation of the Participant’s deferrals to the Plan as
permitted in Section 4.5. 
 c. Death Distribution. Notwithstanding any provision of the Plan or
Participant Election Form to the contrary, in the event of a Participant’s death before the complete distribution of his or her Account, the distribution of such Participant’s Account shall be made in a Lump Sum Payment to the
Participant’s Beneficiary within sixty (60) days after the date of death. 
 5.4 Permissible Acceleration of
Payments. No acceleration of time or schedule of payments under the Plan shall be permitted except as set forth in Section 5.4 or as otherwise permitted under the Plan and Code Section 409A(a)(3). 

a. Distribution for Taxes. The Plan may accelerate payment of all or part of a Participant’s Account to pay or
withhold state, local, or foreign tax obligations; taxes imposed under the Federal Insurance Contributions Act or the Railroad Retirement Act; and any related federal income tax thereon, arising from a Participant’s participation in the Plan.
Such payment of withholding must be limited to the amount necessary to fulfill such tax obligation. 
 b.
Small Payment. Notwithstanding any provision of the Plan to the contrary, if the total value of a Participant’s Account or death benefit payable hereunder is not greater than the applicable dollar amount under Code
Section 402(g)(1)(B), and the Participant is not entitled to a benefit from any other plan that is required to be aggregated with this Plan pursuant to Treasury Regulation Section 1.409A-1(c)(2), the Administrator may distribute such
amount to the Participant or Beneficiary in the form of a Lump Sum Payment. 
 c. Income Inclusion under
409A. Notwithstanding any provision of the Plan to the contrary, in the event that the plan fails to meet the requirements of Code Section 409A, the Administrator may distribute to Participants the portion of their Accounts that is required
to be included in income as a result of such failure. 

  
 10 

 5.5. Permissible Delay of Payment. The Administrator may delay payment to a date
after the designated payment date pursuant to any of the following circumstances, provided that payments to similarly situated Participants are made on a reasonably consistent basis. 

a. Payments that would violate federal securities laws or other applicable law. A payment may be delayed where the
Administrator reasonably anticipates that the making of the payment will violate federal securities laws or other applicable law, provided that the payment is made at the earliest date at which the Administrator reasonably anticipates that the
making of the payment will not cause such violation. For purposes of this Section 5.5(a), the making of a payment that would cause inclusion in gross income or the application of any penalty provision or other provision of the Code is not
treated as a violation of applicable law. 
 5.6. Payment Deemed Timely. A payment shall be treated as made upon the date
specified under the Plan under the following circumstances: 
 a. If the payment is made at such date or a later
date within the same calendar year or, if later, by the fifteenth (15th) day of the third calendar month following the date specified under the Plan. 
 b. If calculation of the amount of the payment is not administratively practicable due to events “beyond the control” of the Participant, or the Participant’s Beneficiary (as such phrase is
defined under Code Section 409A), the payment will be treated as made upon the date specified under the Plan if the payment is made during the first calendar year in which the calculation of the amount of the payment is administratively
practicable. 
 c. If the Company fails to make a payment, in whole or in part, as of the date specified under
the Plan, either, intentionally or unintentionally, the payment will be treated as made upon the date specified under the Plan if (i) the Participant accepts the portion (if any) of the payment that the Company is willing to make (unless such
acceptance will result in a relinquishment of the claim to all or part of the remaining amount), (ii) if the Participant files claims pursuant to Sections 8.6 and 8.7 herein to collect the unpaid portion of the payment, and (iii) any
further payment (including payment of a lesser amount that satisfies the Company’s obligation to make the entire payment) is made no later than the end of the first calendar year in which the Company and the Participant enter into a legally
binding settlement of such dispute, the Company concedes that the amount is payable, or the Company is required to make such payment pursuant to a final and nonappealable judgment or other binding decision. 

5.7. Valuation of Distributions. All distributions under this Plan shall be based upon a daily valuation of the Participant’s
Account or, where applicable, the Fair Market Value of the shares of Company Stock that relate to the Stock Payments or Restricted Stock Units deferred under the Participant’s Account, as determined by the Administrator. 

  
 11 

 ARTICLE VI 
 ACCOUNTS 
 6.1. Account. The Administrator shall establish
and maintain, or cause to be established and maintained, a separate Account for each Participant hereunder who executes an election pursuant to Article IV. Each such Participant’s Deferrable Compensation deferred pursuant to a Election Form
under Article IV shall be separately accounted for and credited with earnings or dividends, as applicable, for recordkeeping purposes only, to his or her Account. A Participant’s Account shall be solely for the purposes of measuring the amounts
to be paid under the Plan. Except as provided in Article VII, the Company shall not be required to fund or secure a Participant’s Account in any way, the Company’s obligation to Participants hereunder being purely contractual. 

6.2. Crediting of Earnings on Non-Stock Compensation. Except as provided in Section 6.3, a Participant may hypothetically
invest his Account in one or more investment alternatives made available by the Administrator, and earnings or losses thereon shall be credited to the Participant’s Account in accordance with the valuation procedures under such investment
alternatives. The Participant shall make his or her investment elections, and changes thereto, on an Election Form in accordance with procedures established by the Administrator. Unless the Administrator determines otherwise, the investment
alternatives available under the Plan shall mirror the alternatives that are made available under the Code Section 401(k) plan sponsored by the Company. 
 6.3. Crediting of Earnings on Restricted Stock Units and Deferred Stock Payments. The portion of a Participant’s Account attributable to Restricted Stock Units and deferral of Stock Payments
shall be deemed invested solely in stock equivalent units of Company Stock, shall be denominated in numbers of stock units, and shall be valued at any time as the stock equivalent units are credited to such Account multiplied by the then-Fair Market
Value of the Company Stock. Whenever a dividend is declared and payable on Company Stock, the number of such stock equivalent units in the Participant’s Account shall be increased by the following calculations: 

(i) the number of units in the Participant’s Account multiplied by any cash dividend declared by the Company on a
share of Company Stock, divided by the Fair Market Value determined as of the related dividend payment date; and/or 
 (ii) the number of units in the Participant’s Account on the related dividend payment date multiplied by any stock dividend declared by the Company on a share of Company Stock. 

In the event of any change in the number or kind of outstanding shares of Company Stock, including a stock split or splits
(other than a stock dividend as provided above), an appropriate adjustment shall be made in the number of units credited to the Participant’s Account. 

  
 12 

 6.4. Statement of Account. As soon as practicable after the end of each Plan Year
(and at such additional times as the Administrator may determine), the Administrator shall furnish each Participant with a statement of the balance credited to the Participant’s Account. 

6.5. Vesting. A Participant is always one hundred percent (100%) vested in his or her Account 

  
 13 

 ARTICLE VII 
 FUNDING AND PARTICIPANTS INTEREST 
 7.1. Plan Unfunded. This
Plan shall at all times be considered entirely unfunded for both federal and state income tax purposes and for purposes of Title I of ERISA, and no trust shall be created by or for the Plan. The crediting to each Participant’s Account shall be
made through recordkeeping entries. No actual funds shall be set aside; provided, however, that nothing herein shall prevent the Company from establishing one or more grantor trusts that meet the requirements of IRS Revenue Procedure 92-64 from
which benefits due under this Plan may be paid in certain instances 
 7.2. Establishment of Grantor Trust. Within
fifteen (15) days following a Change in Control, the Company shall establish under the Plan a grantor trust that meet the requirements of IRS Revenue Procedure 92-64, and shall transfer assets to such trust in amounts sufficient to fully fund
the Plan’s aggregate liability with respect to the Accounts under the Plan on and after the date of the Change in Control. 

7.3. Participants’ Interest in Plan. Notwithstanding Section 7.2 or any other provision of the Plan, a Participant has
an interest only in the value of the amount credited to his or her Account and has no rights or interests in the specific investment funds, stock, or securities in which his or her Account is hypothetically invested under the Plan. All distributions
shall be paid by the Company from its general assets and a Participant (or his or her Beneficiary) shall have the rights of a general, unsecured creditor against the Company for any distributions due hereunder. The Plan constitutes a mere promise by
the Company to make benefit payments in the future. 

  
 14 

 ARTICLE VIII 
 ADMINISTRATION AND INTERPRETATION 
 8.1. Administration. The
Administrator shall be in charge of the overall operation and administration of this Plan. The Administrator has, to the extent appropriate and in addition to the powers described elsewhere in this Plan, full discretionary authority to construe and
interpret the terms and provisions of the Plan; to adopt, alter and repeal administrative rules, guidelines and practices governing the Plan; to perform all acts, including the delegation of its administrative responsibilities to advisors or other
persons who may or may not be Employees; and to rely upon the information or opinions of legal counselor experts selected to render advice with respect to the Plan, as it shall deem advisable, with respect to the administration of the Plan.

 8.2. Interpretation. The Administrator may take any action, correct any defect, supply any omission or reconcile any
inconsistency in the Plan, or in any election hereunder, in the manner and to the extent it shall deem necessary to carry the Plan into effect or to carry out the Company’s purposes in adopting the Plan. Any decision, interpretation or other
action made or taken in good faith by or at the direction of the Company or the Administrator arising out of or in connection with the Plan, shall be within the absolute discretion of each of them, and shall be final, binding and conclusive on the
Company, and all Participants and Beneficiaries and their respective heirs, executors, administrators, successors and assigns. The Administrator’s determinations hereunder need not be uniform, and may be made selectively among Directors,
whether or not they are similarly situated. 
 8.3. Records and Reports. The Administrator shall keep a record of
proceedings and actions and shall maintain or cause to be maintained all such books of account, records, and other data as shall be necessary for the proper administration of the Plan. Such records shall contain all relevant data pertaining to
individual Participants and their rights under this Plan. The Administrator shall have the duty to carry into effect all rights or benefits provided hereunder to the extent assets of the Company are properly available. 

8.4. Payment of Expenses. The Company shall bear all expenses incurred by the Administrator in administering this Plan.

 8.5. Indemnification for Liability. The Company shall indemnify the Committee, the Administrator and the Employees to
whom administrative duties have been delegated under this Plan, against any and all claims, losses, damages, expenses and liabilities arising from their responsibilities in connection with this Plan, unless the same is determined to be due to gross
negligence or willful misconduct. 
 8.6. Claims Procedure. Within ninety (90) days following the date payment was
due in accordance with the terms of the Plan, the Participant or the Participant’s duly authorized representative (hereinafter, the “claimant”) may file a written 

  
 15 

 
request for payment with the Administrator. If a claim for benefits under the Plan is denied in whole or in part, the claimant will receive written notification within forty-five (45) days
following the date of such written request. The notification will include specific reasons for the denial, specific reference to pertinent provisions of this Plan, a description of any additional material or information necessary to process the
claim and why such material or information is necessary, and an explanation of the claims review procedure. To the extent a Participant hereunder is a claimant and serves as an Administrator, he or she shall not participate in any determination
relating to his or her claim, and the Administrator or the Company may appoint an independent individual to take the place of such Participant for purposes of making such determination. 

8.7. Review Procedure. No later than one hundred and eighty (180) days following the date payment was due under the Plan, the
claimant may file a written request with the Administrator for a review of his denied claim. The claimant may review pertinent documents that were used in processing his claim, submit pertinent documents, and address issues and comments in writing
to the Administrator. The Administrator will notify the claimant of his or her final decision in writing. In his or her response, the Administrator will explain the reason for the decision, with specific references to pertinent Plan provisions on
which the decision was based. To the extent a Participant hereunder is a claimant requesting a review and serves as an Administrator, he or she shall not participate in any determination relating to the review, and the Administrator or the Company
may appoint an independent individual to take the place of such Participant for purposes of making such determination. 
 8.8.
Legal Claims. In no event may a claimant commence legal action for benefits the claimant believes are due the claimant until the claimant has exhausted all of the remedies and procedures afforded the claimant by this Article VIII. No such
legal action may be commenced more than two (2) years after the date of the Administrator’s final review decision, described in Section 8.7 above. 
 8.9. Participant and Beneficiary Information. Each Participant shall keep the Administrator informed of his or her current address and the current address of his or her designated beneficiary or
beneficiaries. A Participant may from time to time change his designated Beneficiary without the consent of such Beneficiary by filing a new designation in writing with the Administrator. If no Beneficiary designation is in effect at the time of the
Participant’s death, or if the designated Beneficiary is missing or has predeceased the Participant, distribution shall be made to the Participant’s surviving spouse, or if none, to his surviving children per stirpes, and if none, to his
estate. The Administrator shall not be obligated to search for any person. If such person is not located within one year after the date on which payment of the Participant’s death benefit is payable under the Plan, payment shall be made to the
Participant’s estate. 

  
 16 

 ARTICLE IX 
 AMENDMENT AND TERMINATION 
 9.1. Amendment. The Board shall
have the right, at any time, to amend the Plan or discontinue deferrals under the Plan in whole or in part provided that such amendment or termination complies with Code Section 409A and does not adversely affect the right of any Participant or
Beneficiary to a benefit or payment due under the Plan. The Administrator has the authority, without Board approval, to amend the Plan to comply with the requirements of Code Section 409A, modify the amount or type of compensation that
qualifies as Deferrable Compensation, modify the classes of individuals eligible to participate in the Plan, and to change the investment alternatives offered under the Plan. In addition, the Administrator may make such changes to the Plan’s
operation and administration as it deems to be in the best interest of the Plan. 
 9.2. Termination of Plan. The Board
may take action to provide for the acceleration of the time and form of a payment, or a payment hereunder, where the acceleration of the payment is made pursuant to a termination and liquidation of the Plan in accordance with one of the following:

 a. The termination and liquidation of the Plan pursuant to an irrevocable action taken within the thirty
(30) days preceding or the twelve (12) months following a Change in Control, provided that all agreements, methods, programs, and other arrangements sponsored by the Company or a participating Affiliate immediately after the Change in
Control event with respect to which deferrals of compensation that, together with the Plan, are treated as a single plan for purposes of Treasury Regulation Section 1.409A-1(c)(2) (the “Aggregated Plans”) are terminated and liquidated
with respect to each Participant that experienced the Change in Control event, so that under the terms of the termination and liquidation all such Participants are required to receive all amounts of compensation deferred under the terminated
Aggregated Plans within twelve (12) months of the date of the irrevocable action taken to terminate and liquidate such Aggregated Plans. 
 b. The termination and liquidation of the Plan within twelve (12) months of a corporate dissolution of the Company that is taxed under Code Section 331, or approved by a bankruptcy court
pursuant to 11 U.S.C. Section 503(b)(1)(A), provided that the amounts deferred under the Plan are included in the Participants’ gross incomes in the latest of the following years (or, if earlier, the taxable year in which the amount is actually
or constructively received): 
 (i) The calendar year in which Plan termination and liquidation occurs;

 (ii) The first calendar year in which the amount is no longer subject to a substantial risk of forfeiture; or

  
 17 

 (iii) The first calendar year in which the payment is administratively
practicable. 
 c. The termination and liquidation of the Plan, where: 

(i) Such termination and liquidation does not occur proximate to a downturn in the financial health of the Company or the
Affiliate, as applicable; 
 (ii) To the extent the same Participant had deferrals of thereunder, all Aggregated
Plans are likewise terminated and liquidated; 
 (iii) No payments in liquidation of the Plan are made within
twelve (12) months of the date the irrevocable action is taken to terminate and liquidate the Plan, other than payments that would be payable under the terms of the Plan if the action to terminate and liquidate the Plan had not occurred;

 (iv) All payments are made within twenty-four (24) months of the date the irrevocable action is taken to
terminate and liquidate the Plan; and 
 (v) The Company and Affiliate, as applicable, does not adopt a new plan
that would be aggregated with the Plan if the Participant participated in both plans, at any time within three years following the date the irrevocable action is taken to terminate and liquidate the Plan. 

d. Any other termination and liquidation event that is permissible under Code Section 409A. 

  
 18 

 ARTICLE X 
 MISCELLANEOUS PROVISIONS 
 10.1. Right of Company to Take
Actions. The adoption and maintenance of this Plan shall not be deemed to constitute a contract between the Company and a Director, or to be a consideration for, nor an inducement or condition of, the employment of any person. Nothing herein
contained, or any action taken hereunder, shall be deemed to give a Director the right to be retained in the service of the Board or to interfere with the right of the Board to discharge the Director at any time, nor shall it be deemed to give to
the Board the right to require the Director to remain in its employ, nor shall it interfere with the Director’s right to terminate his or her service at any time. Nothing in this Plan shall prevent the Company from amending, modifying, or
terminating any other benefit plan. 
 10.2. Alienation or Assignment of Benefits. Except as otherwise provided under the
Plan, a Participant’s rights and interest under the Plan shall not be assigned or transferred except as otherwise provided herein, and the Participant’s rights to benefit payments under the Plan shall not be subject to alienation, pledge
or garnishment by or on behalf of creditors (including heirs, beneficiaries, or dependents) of the Participant or of a Beneficiary. 
 10.3. Company’s Protection. By execution of an Election Form, each Participant shall be deemed to have agreed to cooperate with the Company by furnishing any and all information reasonably
requested by the Administrator in order to facilitate the payment of benefits hereunder. 
 10.4. Construction. All legal
questions pertaining to the Plan shall be determined in accordance with the laws of the Commonwealth of Pennsylvania; to the extent such laws are not superseded by ERISA or any other federal law. 

10.5. Headings. The headings of the Articles and Sections of this Plan are for reference only. In the event of a conflict between
a heading and the contents of an Article or Section, the contents of the Article or Section shall control. 
 10.6. Number
and Gender. Whenever any words used herein are in the singular form, they shall be construed as though they were also used in the plural form in all cases where they would so apply, and references to the male gender shall be construed as
applicable to the female gender where applicable, and vice versa. 
 10.7. Right to Withhold. To the extent required by
law in effect at the time a distribution is made from the Plan, the Company or its agents shall have the right to withhold or deduct from any distributions or payments any taxes required to be withheld by federal, state or local governments.

 * * * * * 

  
 19 

 Approved and adopted by the Board of Directors this 13th day of December, 2007. 

  
 20Supply  Agreement dated as of January 1, 2001

 Exhibit 10.17 
 The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the
Securities and Exchange Act of 1934, as amended. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***. 
 SUPPLY
AGREEMENT 
 This Agreement made by and between VINTAGE PHARMACEUTICALS, INC., an Alabama corporation (hereinafter
“VINTAGE”) and NORAMCO, a division of McNeilab, Inc., a Pennsylvania corporation (hereinafter “NORAMCO”). 

In consideration of the mutual promises, covenants and agreements hereinafter set forth, the parties hereto agree as follows: 

1. Definitions When used herein, the following terms shall have the meanings specified below: 

1.1 “Affiliate” of a party to this Agreement shall mean any corporation or partnership or other entity which directly or
indirectly controls, is controlled by or is under common control with such party. “Control” shall mean the legal power to direct or cause the direction of the general management or partners of such entity whether through the ownership of
voting securities, by contract or otherwise. 
 1.2 “Available Requirements” shall be that portion of VINTAGE’S
total annual requirements for a Product for which VINTAGE has approval from, and is in good standing with, the FDA to use NORAMCO material and for which NORAMCO is a supplier approved by the Federal Food and Drug Administration. 

1.3 “Products” shall mean ***. 
 1.4 “Term” shall mean the term of this Agreement, which shall be for a period commencing on January 1, 2001, the effective date of this Agreement and terminating unless sooner terminated
pursuant to this Agreement, on December 31, 2005. 
 1.5 “Territory” shall mean the fifty (50) states of the
United States of America and the District of Columbia. 
 2. Purchase and Sale of Products 

a) During the term of this Agreement, NORAMCO shall, in a timely manner, supply VINTAGE with those quantities of Products as ordered by
VINTAGE pursuant to this Agreement. The Products shall conform to the specifications set forth in Exhibit A, Exhibit B, and Exhibit C to this Agreement and as may subsequently be mutually agreed upon in writing by the parties hereto (the
“Product Specifications”). 
 b) The prices to be charged by NORAMCO to VINTAGE as set forth in Section 4 hereof
shall include all delivery costs for F.O.B. destination. The risk of loss with respect to Products shall remain with NORAMCO until Products are delivered to VINTAGE at its facilities or at such other location as shall be designated by VINTAGE as a
point of delivery. 

  

					
		  	1	  	

 NORAMCO shall pack all Products ordered hereunder in individual package size quantities as specified by
VINTAGE, or as agreed to by the parties, in a manner suitable for safe shipment. Payment terms on all orders shall be net *** days except by mutual consent. VINTAGE shall remit payment for each respective order of Products which it places pursuant
to this Agreement within *** days of its receipt of such ordered Products (and applicable invoices therefor), provided that such Products comply with the terms of this Agreement. If at any time, VINTAGE’S payment obligations to NORAMCO are in
arrears, NORAMCO shall have the right to refuse to supply any further Product to VINTAGE until the arrearage has been satisfied. 
 c) (1) In the event VINTAGE wishes to change a specification after execution of the Agreement, NORAMCO will calculate the cost and advise VINTAGE of the one time charge. VINTAGE may either remit or
elect not to change the specification. 
 If NORAMCO is required to change any specification in order to meet then-applicable
regulatory requirements, NORAMCO will promptly notify VINTAGE of such changes and the cost of such changes. If VINTAGE is unable or unwilling to make necessary changes as a result of the NORAMCO changes, VINTAGE will have the option of terminating
the Agreement. 
 (2) During the term of this Agreement, NORAMCO agrees to notify VINTAGE of any and all proposed process
changes, or specification changes which may materially effect the integrity and/or quality of the Product or which may or shall be considered a material change by the FDA or shall require a supplement to the FDA. NORAMCO further agrees that it will
supply VINTAGE with samples of Product which have undergone process or specification changes, described above, permitting VINTAGE the time and opportunity to perform necessary testing, reformulation, filing with the FDA, and receive FDA approval, if
required prior to shipment of Product for production batches to VINTAGE. Upon receipt of the new specification samples supplied by NORAMCO, it shall be the duty of VINTAGE to perform all required acts in a timely manner. NORAMCO shall continue to
uninterruptedly supply Product to VINTAGE consistent with VINTAGE’S approved Product’s Specification Sheet according to and consistent with VINTAGE purchase orders until approval is received by VINTAGE from the FDA, if required, for the
product manufactured under the new process. NORAMCO agrees to supply VINTAGE with Product, which conforms to VINTAGE specification as filed and approved by the FDA, which has not undergone a process or specification change, described above, until
such time that VINTAGE has received approval by the FDA, if required, for the new process Product. 
 (3) NORAMCO shall Provide
to VINTAGE, without charge, all statistical, analytical and laboratory testing methods of the product including known impurities, degradents, etc., as needed and required for NDA and ANDA submissions, or other FDA requests and/or requirements.

 3. Purchase Agreement During the term of this Agreement and subject to the terms, conditions and limitations herein set forth,
and further subject to NORAMCO’S ability to supply VINTAGE’S requirements, VINTAGE shall purchase from NORAMCO at least *** of VINTAGE’S Available Requirements for Products to be sold in the Territory for which VINTAGE has received
FDA approval, remains in good standing, and continues to own the ANDA or continues to manufacture the Product(s) as authorized by the NDA or ANDA. If 

  

					
		  	2	  	

 
NORAMCO cannot supply VINTAGE’S Available Requirements, VINTAGE shall have the option of sourcing the Product that NORAMCO is unable to supply from another qualified supplier, subject to the
terms of Section 5 hereof. 
 4. Pricing 
 A. Base Price 
 The base price to be charged by NORAMCO for each
Product during the calendar year 2001 shall be: 
  

					
	 ***
	  	$	*	** 
	 *** 
	  	$	*	** 
	 *** 
	  	$	*	** 

 When VINTAGE purchases from NORAMCO a
quantity of each Product during the calendar year equal to the Qualifying Quantity in the following chart, VINTAGE shall be entitled to a rebate equal to: 
 ((Qualifying Quantity) multiplied by (Amount of Rebate Per Kilogram)) less (any rebates already paid during the calendar year in accordance with this Section of 4A). 

The rebate shall be calculated by NORAMCO and paid to VINTAGE within thirty (30) days of the end of each quarter. 

 

													
	 	  	Base Price 
Per
Kilogram	 	 	Rebate
Qualifying
Quantity	 	 	Rebate Per
Kilogram	 
	 	  	 	 
	 	  	 	 
	 *** 
	  				 				 			
	 0 to 1,000 kg
	  	$	*	** 	 	 	*	** 	 	$	*	** 
	 1,001 to 2,000
	  	$	*	** 	 	 	*	** 	 	$	*	** 
	 2,001 to 3,000
	  	$	*	** 	 	 	*	** 	 	$	*	** 
	 3,001 or more
	  	$	*	** 	 	 	*	** 	 	$	*	** 
				
	 *** 
	  				 				 			
	 0 to 2,000 kg
	  	$	*	** 	 	 	*	** 	 	$	*	** 
	 2,001 to 2,500
	  	$	*	** 	 	 	*	** 	 	$	*	** 
	 2,501 to 3,500
	  	$	*	** 	 	 	*	** 	 	$	*	** 
	 3,501 to 5,000
	  	$	*	** 	 	 	*	** 	 	$	*	** 
	 5,001 or more
	  	$	*	** 	 	 	*	** 	 	$	*	** 
				
	 *** 
	  	$	*	** 	 	 	*	** 	 	 	*	** 

  

					
		  	3	  	

 B. Escalation 

The Base Price per kilogram of each of the Products is the sum of a “Raw Materials Component” and an “Other Costs
Component”. For each product, the Raw Material Component for Base 2001 is shown below: 
  

					
	 	  	Raw Material Component	 
	 ***
	  	$	*	** 
	 ***
	  	$	*	** 
	 ***
	  	$	*	** 

 The other Costs Component is the Base
Price less the Raw Material component. 
 Beginning on January 1, 2002, and on each ensuing January 1, all prices set forth above are
subject to automatic changes on an annual basis. Such changes shall be limited to the sum of the following changes: 
  

	 	1)	The change in the “Raw Materials Component” shall be in the proportion as the change in the then-current price of *** over the March 2001 *** price as
determined by the Government of ***. NORAMCO will have its Certified Public Accountants verify the *** price increases at VINTAGE’S request. 

 In addition, if during the calendar year, *** prices increase or decrease by a total of ***% or more, an adjustment as described above will be made three (3) months after the effective date of the
*** price increase or decrease which is in excess of ***% over the January 1 price for that year. 
  

	 	2)	The change in the “Other Costs” component shall be in the same proportion as NORAMCO’S actual cost increase not to exceed the percentage increase in the
then current Producer Price Index over the December 2000 Producer Price Index. 

 C. *** Market Subsidy

 Beginning January 1, 2002 if NORAMCO’S total shipments, or VINTAGE purchase orders, of *** exceed *** kilograms
during a given calendar year, VINTAGE shall receive a “Market Subsidy” based on VINTAGE’S production of *** SKUs. The amount of this Market Subsidy will be calculated by VINTAGE at the end of the calendar year as follows; 

(Subsidized Quantity) times (Subsidy Price) 
  

	 	1.	The “5/500 Percentage” shall be defined as the percentage of VINTAGE’S total usage of *** during the calendar year used for production of *** 5/500 SKUs.

  

	 	2.	The “Subsidized Quantity” shall be defined as the lesser of: 

  

	 	A)	(VINTAGE’S total purchases of *** from NORAMCO during the calendar year) times (the 5/500 Percentage) 

  

					
		  	4	  	
 

	 	B)	VINTAGE’S total purchases of *** from NORAMCO during the calendar year) times (***): 

 

	 	3.	The “Subsidy Price” shall be defined as: 

 ($*** Per Kilogram) less (the Rebate Per Kilogram in Section 4A and 4B which was applicable and has been paid to VINTAGE for the calendar year) 

VINTAGE shall invoice NORAMCO for the amount of the Market Subsidy at the end of the calendar year. NORAMCO shall pay the amount within 30 days of
receipt of this invoice. VINTAGE will have its Certified Public Accountants verify the 5/500 Percentage at NORAMCO’S request. 
 The Market
Subsidy shall be reviewed at the end of 2003. VINTAGE’S average selling price per bottle of *** *** 5/500 tablets in 2000 was $***. VINTAGE shall calculate the comparable price per bottle for 2003. If it is higher in 2003, the amount of
the Market Subsidy shall be reduced during calendar 2004 by $*** per kilogram of *** for every $*** per bottle increases between 2000 and 2003 in the average selling price per bottle. This review will be repeated at the end of 2004. 

If VINTAGE identifies other opportunities in which NORAMCO can support its growth, NORAMCO will agree to meet with VINTAGE and review the opportunity for
collaboration. 
 D. Market Price Adjustment 

If VINTAGE receives a written quote from a supplier who is approved by DEA as a manufacturer of the Product which meets the following
conditions: 
  

	 	1)	The supplier is qualified by VINTAGE and approved by the FDA 

  

	 	2)	The offer is to supply at least ***% of VINTAGE’S Available Requirements. 

 

	 	3)	The quoted price per kilogram (“Quoted Price”) is lower than the price per kilogram after all applicable rebates in Sections 4A, 4B, 4C (“Supply
Price”) for the remaining term of this agreement. 

  

	 	4)	The quote includes a provision equivalent to the terms in Section 5. 

 NORAMCO will adjust its Supply Price as follows: 
  

	 	A.	If the Quoted Price is for only one Product and it is between ***% less than the Supply Price: 

No Adjustment 
  

	 	B.	If the Quoted Price is for all Products or more than ***% below the Supply Price for one Product, NORAMCO will reduce its Supply Price by an amount equal to:

 (Supply Price) less (Quoted Price) equals (Amount of Rebate Per Unit) 

  

					
		  	5	  	
 

 NORAMCO will have the right to verify the terms of the written quote and the status of the supplier.

 NORAMCO will have the right to cancel all or part of this Agreement if the Section 4D is invoked. 

E. Qualification of NORAMCO’s Athens, Georgia Facility to Supply *** 

If, at NORAMCO’s request, VINTAGE agrees in writing to qualify *** produced at NORAMCO’s Athens, Georgia facility for use in VINTAGE SKUs whose
total usage of *** equals at least ***% of Available Requirements, NORAMCO will reimburse VINTAGE in the amount of *** ($***). 
 This
reimbursement shall be paid on the earlier of: 
  

	 	1)	The date NORAMCO successfully validates *** in its Athens, Georgia facility. The *** produced in Athens will meet all specifications in Exhibit B.

  

	 	2)	July 1,2002 

 This reimbursement shall be
returned to NORAMCO if VINTAGE is unable to utilize *** in VINTAGE SKU’s whose total usage of *** equals at least *** (***%) of Available Requirements within twelve months of the date NORAMCO is able to supply *** from three validation
batches meeting all specifications in Exhibit B. 
 5. Failure to Supply Beginning January 1, 2002, failure to supply shall
occur if: 
  

	 	A.	NORAMCO is unable to deliver within a calendar month an ordered amount of Product equal to ***% of VINTAGE’S Available Requirements divided by twelve.

  

	 	B.	VINTAGE replaces this shortfall by purchasing an amount of product from a third party. 

 

	 	C.	Failure to Supply is not due to a Force Majeure event. 

 The “Shortfall Quantity” shall be the lesser of: 
  

	 	A.	***% of VINTAGE’S Available Requirements) divided by (twelve)) less the (actual shipments of Product during the calendar month) or, 

 

	 	B.	The replacement quantity purchased by VINTAGE. 

  

					
		  	6	  	
 

 The Shortfall Quantity for a calendar year may be changed to a fixed number of kilograms of
Product by mutual consent of the parties. 
 If Failure to Supply occurs, NORAMCO shall reimburse VINTAGE as follows: 

((actual price per kilogram as paid to the third party) less (the applicable price VINTAGE would have paid to NORAMCO during the month
Failure to Supply occurred under the terms in Section 4)) times (the Shortfall Quantity) 
 VINTAGE shall use reasonable commercial efforts
to minimize the amount of this reimbursement. 
 The total reimbursements for all Failures to Supply within a calendar quarter shall be
calculated by VINTAGE and invoiced to NORAMCO. VINTAGE shall, at NORAMCO’S request, provide documentation supporting the calculation of the reimbursement. 
 The quantity of the total number of kilograms required to be purchased by VINTAGE from a third party shall be considered a delivery for purposes of determining the total number of kilograms to be used to
calculate Rebate Amounts in Section 4C of this amendment. 
 6. Specifications and Changes 

NORAMCO does hereby agree to supply VINTAGE with the Product which shall conform to the attached specifications. 

NORAMCO agrees to notify VINTAGE prior to all changes in Product specifications which shall affect the regulatory status of the VINTAGE product. VINTAGE
agrees to qualify process changes or site changes which require Changes Being Effected filings with the Food and Drug Administration. 
 NORAMCO
does hereby grant permission to VINTAGE to reference as needed NORAMCO’S Drug Master Files for the Products. 
 7. *** Price
Protection If, as a result of entering into this Agreement, VINTAGE experiences an increase in the price charged to it by its supplier of ***, NORAMCO will apply a credit against the future purchases from it of the Products hereunder. The
amount of the credit will be: 
 (Average Purchase price minus $*** per Kilogram) times (Kilograms of *** purchased by VINTAGE during the
calendar year) 
 The “Average Purchase price” shall be the actual average price per kilogram paid by VINTAGE for *** during a
calendar year. 
 In no event shall the cumulative credit extended during a calendar year under this provision exceed the sum of $***.

  

					
		  	7	  	
 

 8. Forecast and Orders (a) On an annual basis, at the beginning of each calendar year
during the term of this Agreement, VINTAGE shall provide NORAMCO with a non-binding written forecast of VINTAGE’S expected requirements for Products during that year. This forecast shall be updated at the beginning of each calendar quarter.
VINTAGE shall place binding orders for Products which shall include package sizes required by written purchase order to NORAMCO, which shall be placed at least thirty (30) days prior to the desired date of delivery. 

b) To the extent of any conflict or inconsistency between this Agreement and any purchase order, purchase order release, confirmation,
acceptance or any similar document, the terms of this Agreement shall govern. 
 c) VINTAGE will notify NORAMCO if it expects to
launch new SKUs which are expected to increase VINTAGE’S Available Requirements for *** or *** by more than 1,000 kilograms within the following twelve months. Upon notification, NORAMCO and VINTAGE will work out a mutually acceptable plan to
meet VINTAGE requirements. 
 9. Acceptance of Products: Corrective Actions a) Delivery of any Product by NORAMCO to VINTAGE shall
constitute a certification by NORAMCO that the Product has been tested, has been found to conform fully to the Product Specifications and is free from defects in design, material and workmanship. The test methods and data shown on the Certificate of
Analysis shall be mutually agreed upon by NORAMCO and VINTAGE. 
 After delivery of a shipment of any Products to VINTAGE, VINTAGE shall have
thirty (30) days to examine the Products to determine if they conform to the Product Specifications and if they are free from defects in design, material and workmanship, and on the basis of such examination, to accept or reject such shipment.
Any claims for failure to conform or for such defects (“Claims”) shall be made by VINTAGE in writing to NORAMCO, indicating the nonconforming characteristics in test methods prior to any return of unacceptable Product to NORAMCO. NORAMCO
will not accept return of opened containers without a certification from VINTAGE that they were stored and sampled in conformance with Good Manufacturing Practices. NORAMCO shall pay for all shipping costs of returning Products that are subject of
Claims. 
 b) Any shipment of Products for which VINTAGE shall not submit a Claim within thirty (30) days of delivery shall
be deemed accepted. Upon acceptance, VINTAGE shall release NORAMCO from all Claims for non-conformity of defects except Claims for latent defects which are not reasonably detectable at the time of acceptance. The acceptance by VINTAGE of such
Products shall not constitute a waiver of any rights of VINTAGE or a release of any obligations of NORAMCO except those rights and obligations set forth in Section 9. 
 10. Representations and Warranties NORAMCO represents and warrants to VINTAGE that all Products supplied in connection with this Agreement shall be of merchantable quality, fit for the
purposes intended by this Agreement and free from defects in material and workmanship and shall be manufactured and provided by NORAMCO in accordance and conformity with the Product Specifications and in compliance with this Agreement. All such
Products shall meet U.S. Food and Drug Administration and U.S. Drug Enforcement Agency standards and requirements for product to be lawfully shipped and sold. 

  

					
		  	8	  	
 

 NORAMCO will allow VINTAGE to refer to the Drug master Files of the Products in support of any of its
applications for the FDA. 
 11. Inspection of Premises VINTAGE shall have the right, upon reasonable notice to NORAMCO and during
regular business hours, to inspect and audit the facilities being used by NORAMCO for production of the Products to assure compliance by NORAMCO with applicable rules and regulations and with other provisions of this Agreement. 

12. Indemnification a) NORAMCO shall indemnify and hold harmless VINTAGE and its Affiliates and their officers, directors, and employees
from and against any and all claims, losses, damages, judgments, costs, awards, expenses (including reasonable attorneys’ fees) and liabilities of every kind (collectively, “Losses”) arising directly out of or resulting directly from
any breach by NORAMCO of any of its warranties, guarantees, representations, obligations or covenants contained herein. 
 b)
VINTAGE agrees to give NORAMCO prompt written notice of any matter upon which VINTAGE intends to base a claim for indemnification (an “Indemnity Claim”). NORAMCO shall have the right to participate jointly with VINTAGE in VINTAGE’S
defense, settlement or other disposition of any Indemnity Claim. With respect to any Indemnity Claim relating solely to the payment of money damages and which could not result in VINTAGE’S becoming subject to injunctive or other equitable
relief or otherwise adversely affect the business of VINTAGE in any manner, and as to which NORAMCO shall have acknowledged in writing the obligation to indemnify VINTAGE hereunder, NORAMCO shall have the sole right to defend, settle or otherwise
dispose of such indemnity Claim, on such terms as NORAMCO, in its sole discretion, shall deem appropriate, provided that NORAMCO shall provide reasonable evidence of its ability to pay any damages claimed and with respect to any such settlement
shall have obtained the written release of VINTAGE from the Indemnity Claim. NORAMCO shall obtain the written consent of VINTAGE, which shall not be unreasonably withheld, prior to ceasing to defend, settling or otherwise disposing of any Indemnity
Claim if as a result thereof VINTAGE would become subject to injunctive or other equitable relief or the business of VINTAGE would be adversely effected in any manner. 
 c) This article shall survive any termination of this Agreement. 
 13. Term
After December 31, 2005, this Agreement shall automatically renew for additional one-year terms unless, at least six (6) months prior to the termination date or the closing date of any subsequent renewal period, either party provides
written notice to the other of its intention to terminate. 
 14. Termination a) This Agreement may be terminated, prior to its
original termination date or any subsequent renewal period termination date, upon fifteen (15) days notice by either party in the event that the other party hereto shall file a petition or receive service of an involuntary petition seeking to
take advantage of any other law relating to bankruptcy, insolvency, reorganization, winding-up, or composition or readjustment debts. 
 b) This Agreement may be terminated, prior to its termination date by either party giving notice of its intent to terminate and stating the grounds therefor if the other party shall

  

					
		  	9	  	
 

 
materially breach or materially fail in the observance or performance of any representation, warranty, guarantee, covenant or obligation under this Agreement. The party receiving the notice shall
have sixty (60) days from the date of receipt thereof to cure the breach or failure. In the event such a breach or failure is cured, the notice shall be of no effect. 
 c) Notwithstanding the termination of this Agreement for any reason, each party hereto shall be entitled to recover any and all damages which such party shall have sustained by reason of the breach by the
other party hereto of any of the terms of this Agreement. Termination of this Agreement for any reason shall not release either party hereto from any liability which at such time has already accrued or which thereafter accrues from a breach or
default prior to such expiration or termination, nor affect in any way the survival of any other right, duty or obligation of either party hereto which is expressly stated elsewhere in this Agreement to survive such termination. 

15. Force Majeure If either party is prevented from performing any of its obligations hereunder due to any cause which is beyond the
non-performing party’s reasonable control, including fire, explosion, flood, or other acts of God; acts, regulations, or failure of public utilities or common carriers (a “Force Majeure Event”), such non-performing party shall not be
liable for breach of this Agreement with respect to such non-performance to the extent any such non-performance is due to a Force Majeure Event. Such non-performance will be excused for three (3) months or as long as such event shall be
continuing (whichever occurs sooner), provided that the non-performing party gives immediate written notice to the other party of the Force Majeure Event. Such non-performing party shall exercise all reasonable efforts to eliminate the Force Majeure
Event and to resume performance of its affected obligations as soon as practicable. 
 16. Taxes VINTAGE shall assume liability
for all taxes, excises or other charges which relate to the Products and are imposed by any local, state or federal authority after title to the Products passes to VINTAGE. VINTAGE further agrees to indemnify NORAMCO against any and all such
liability for taxes as well as any reasonable legal fees or costs incurred by NORAMCO in connection therewith. To the best of NORAMCO’S knowledge, there are no such taxes, excises or other charges now in effect. 

17. Relationship of the Parties The Relationship of VINTAGE and NORAMCO established by this Agreement is that of independent contractors,
and nothing contained herein shall be construed to (i) give either party any right or authority to create or assume any obligation of any kind on behalf of the other or (ii) constitute the parties as partners, joint venturers, co-owners or
otherwise as participants in a joint or common undertaking. 
 18. Publicity Neither party shall originate any publicity, news
release, or other announcement, written or oral, whether to the public press, the trade, their customers or otherwise, relating to this Agreement or to the existence of any arrangement between the parties without the prior written approval of the
other party. 
 19. Construction This Agreement shall be governed by, and shall be construed in accordance with, the laws of the
State of New Jersey. 

  

					
		  	10	  	
 

 20. Entire Agreement This Agreement (i) constitutes the entire agreement and
understanding between the parties with respect to the subject matter hereof and there are no promises, representation, conditions, provision or terms related thereto other than those set forth in this Agreement and (ii) supersedes all previous
understandings, agreements and representations between the parties, written or oral. No modification, change or amendment to this Agreement shall be effective unless in writing signed by each of the parties hereto. 

21. Headings The headings used herein have been inserted for convenience only and shall not affect the interpretation of this Agreement.

 22. Notices All notices and other communications hereunder shall be in writing and delivered personally or mailed by overnight,
U.S. mail, postage prepaid, or by certified or registered U.S. mail, return receipt requested, postage prepaid, or sent by Federal Express or another internationally recognized courier service (billed to sender), to the following addresses:

  

					
	if to NORAMCO:	  	 NORAMCO of Delaware, Inc.
 824 Marke Street, Suite 860
 Wilmington, DE 19801

ATTN: Vice President Administration

		
	if to VINTAGE:	  	 VINTAGE Pharmaceuticals, Inc.
 130 Vintage Drive
 Huntsville, AL 35811

ATTN: William S. Propst, Sr., President

		  	 Telephone: 
	  	(256) 859-4011
		  	 Fax: 
	  	(256) 859-2903

 or to such other place as either party may
designate by written notice to the other. 
 23. Failure to Exercise The failure of either party to enforce at any time for any
period any provision hereof shall not be construed to be a waiver of such provision or of the right of such party thereafter to enforce each such provision, nor shall any single or partial exercise of any right or remedy hereunder preclude any other
or further exercise thereof or the exercise of any other right or remedy. Remedies provided herein are cumulative and not exclusively of any remedies provided at law. 
 24. Assignment This Agreement may not be assigned by either party without the prior written consent of the other, except that VINTAGE or NORAMCO may assign its rights and/or obligations
hereunder to any of its Affiliates. Subject to the foregoing sentence, this Agreement shall bind and inure to the benefit of the parties hereto and respective successors and assigns. 
 25. Severability Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, to the extent the economic benefits conferred by this Agreement to both
parties remain substantially unimpaired, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability
of any of the terms or provisions of this Agreement in any other jurisdiction. 

  

					
		  	11	  	

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by
their duly authorized respective representatives as of the day and year first above written. 
  

									
	 VINTAGE PHARMACEUTICALS, INC.
 an Alabama corporation
	 		 	 NORAMCO, a division of McNeilab, Inc.
 a Pennsylvania corporation

					
	BY:	 	
 

	 		 	BY:	 	
 

				
	NAME:	 	William S. Propst, Sr.	 		 	 NAME: Michael B. Kindergan

	TITLE:	 	President	 		 	TITLE:	 	Vice President, Administration

  

					
		  	12	  	
 

 EXHIBIT A 
 *** 
  
  

  

 EXHIBIT B 
 *** 
  
  

  

 EXHIBIT C 
 ***

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}]]